2022 Q2 International Update Matthew Nigro·May 13, 2022 CEM is the company it is today because of all of you. I want to...CEM VisionMarketing UpdatesMike Collins·0 Comments·0
CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production Matthew Nigro·January 20, 2022CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP...CEM VisionMarketing UpdatesMike Collins·0 Comments·0
Catch the Vision 2021: A Message from Mike Collins Sr. Mike Collins·December 1, 2020I had hoped to bring this message to you in person; however, we must continue to keep everyone...CEM VisionMarketing UpdatesMike Collins·0 Comments·0
Mike Sr. Discusses CEM’s First Acquisition Matthew Nigro·November 14, 2019As was announced last week CEM acquired the key assets of Intavis Bioanalytical Instruments. This acquisition represents a...CEM VisionMarketing UpdatesMike CollinsSales Updates·0 Comments·0
Mike Sr Addresses Media at PittCon 2019 Matthew Nigro·June 5, 2019At Pittcon 2019, Mike Collins discussed how four new technologies are transforming the world of chemical analysis, food...CEM VisionMarketing UpdatesMike CollinsSales Updates·0 Comments·0
Mike Collins on the Life Science Marketing Radio Podcast Matthew Nigro·January 16, 2019Mike was highlighted on a the Life Science Marketing Radio podcast. Listen to what Mike has to say...CEM VisionMarketing UpdatesMike CollinsSales Updates·0 Comments·0
Change. Patience. Reward: A Message from Mike Collins Sr. Matthew Nigro·August 6, 2018Obviously, it is an exciting time for CEM with good growth, strong new products and a major facilities...CEM VisionMarketing UpdatesMike CollinsSales Updates·0 Comments·0